المراجع
- Aspirin C PIL
- Aspirin protect PIL
- NATIONAL ACADEMY PRESS Washington, D.C. 1987
- Aspirin 500 PIL
- World Health Organization, Media Centre, Fact sheet N°277, Headache Disorders, October 2012
- Source: http://www.nhs.uk/conditions/headaches-tension-type/Pages/Introduction.aspx
- http://www.nhs.uk/Conditions/Migraine/Pages/Introduction.aspx
- http://www.nhs.uk/Conditions/Migraine/Pages/Symptoms.aspx
- http://www.nhs.uk/Conditions/Migraine/Pages/Prevention.aspx
- Standards of Medical Care in Diabetes 2016 January 2016 Volume 39, Supplement 1
- http://www.nhs.uk/Conditions/Sports-injuries/Pages/Introduction.aspx
- http://www.nhs.uk/Conditions/Back-pain/Pages/Causes.aspx
- http://www.nhs.uk/Livewell/workplacehealth/Pages/backpainatwork.aspx
- http://www.nhs.uk/Livewell/Backpain/Pages/Backexercises.aspx
- http://www.nhs.uk/Livewell/fitness/Pages/sitting-and-sedentary-behaviour-are-bad-for-your-health.aspx
- http://www.nhs.uk/conditions/Headache/Pages/Introduction.aspx
- http://www.nhs.uk/Conditions/Migraine/Pages/Causes.aspx
- Aspirin is Efficacious for the treatment of acute migraine Lipton_et_al-2005-Headache__The_Journal_of_Head_and_Face
- Aspirin and tension-type headache - Ivano Farinelli , Paolo MartellettiJ - Headache Pain (2007) 8:49–55
- http://www.nhs.uk/livewell/backpain/pages/topbacktips.aspx
- http://www.nhs.uk/Conditions/Back-pain/Pages/Treatment.aspx
- http://www.nhs.uk/conditions/stress-anxiety-depression/pages/ways-relieve-stress.aspx
- http://www.rheumatology.org/I-Am-A/Patient-Caregiver/Treatments/NSAIDs
- http://www.nhs.uk/livewell/coldsandflu/pages/isitacoldorflu.aspx
- http://www.nhs.uk/conditions/Flu/Pages/Introduction.aspx
- Terrie YC. Stopping the Symptoms of Cough, Cold, and Flu-When recommending OTC products for these common ailments, a careful patient assessment is an important first step. Pharmacy Times 2012; 78: 12
- http://www.nhs.uk/livewell/coldsandflu/pages/isitacoldorflu.aspx
- http://www.nhs.uk/Livewell/coldsandflu/Pages/Preventionandcure.aspx
- http://www.nhs.uk/Livewell/smoking/Pages/Betterlives.aspx
- https://www.healthdirect.gov.au/colds-and-flu
- http://www.who.int/mediacentre/factsheets/2003/fs211/en/
- http://www.who.int/mediacentre/factsheets/fs211/en/
- http://www.nhs.uk/livewell/coldsandflu/pages/isitacoldorflu.aspx
- A Statement for Healthcare Professionals From the American Heart Association and the Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations Circulation. 1999;100:1481-1492
- http://www.world-heart-federation.org/cardiovascular-health/cardiovascular-disease-risk-factors/
- http://www.nhs.uk/Conditions/cardiovascular-disease/Pages/Introduction.aspx
- Source: Assessment and Management of Conditions Specifically Related to Stress: mhGAP Intervention Guide Module (version 1.0). Geneva: WHO, 2013.
- Antithrombotic Trialists’ (ATT) Collaboration* Lancet 2009; 373: 1849–60
- ANDREW SZCZEKLIK - THE HISTORY OF ASPIRIN THE DISCOVERIE Paths of Discovery Pontifical Academy of Sciences, Acta 18, Vatican City 2006 http://www.pas.va/content/dam/accademia/pdf/acta18/acta18-szczeklik.pdf
- http://www.who.int/mediacentre/factsheets/fs317/en/
- Heart Disease, Stroke and Research Statistics At-a-Glance https://www.heart.org/idc/groups/ahamah-public/@wcm/@sop/@smd/documents/downloadable/ucm_480086.pdf
- http://www.medscape.com/viewarticle/567740
- Review Article The mechanism of action of aspirin J.R. Vane, R.M. Botting ; Thrombosis Research 110 (2003) 255–258
- Aspirin the novel antiplatelet drug D Pawar, S Shahani, S Maroli HKMJ 1998;4:415-8
- http://americanhistory.si.edu/collections/search/object/nmah_1422653
- Evaluation of the Benefit and risk of low dose Aspirin is the secondary prevention of cardio vascular and cerebrovascular events Steven M Weisman , David Y. Graham ; Arch intern Med 2002 162:2 197-2202
- Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321(3):129–135
- The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978;299:53–59
- WHO - Global atlas on cardiovascular disease prevention and control 2011
- http://www.who.int/mediacentre/factsheets/fs317/en/
- https://www.cdc.gov/healthyweight/losing_weight/
- http://www.nhs.uk/conditions/nhs-health-check/pages/tools-and-technology-that-can-help.aspx
- Walter Sneader, The discovery of aspirin: a reappraisal, BMJ. 2000 Dec 23; 321(7276): 1591–1594.
- Kagan Ipci et al, Effervescent tablets: a safe and practical delivery system for drug administration, ENT Updates 2016;6(1):46–50
- http://www.nature.com/nsmb/journal/v10/n4/full/nsb0403-233.html
- https://www.nhlbi.nih.gov/health/health-topics/topics/hhw/anatomy
- David Gregg, et al, Platelets and Cardiovascular Disease, Circulation. 2003;108:e88-e90
- https://www.bayer.com/en/history.aspx
- COCEANI et al, Prostaglandin E2 And Fever: A Continuing Debate THE YALE JOURNAL OF BIOLOGY AND MEDICINE 59 (1986), 169-174
- Vane, J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirinlike drugs.Nature (London) New Biology 231:232-235, 1971.
- http://www.nhs.uk/Conditions/Back-pain/Pages/Prevention.aspx
- http://www.bayer.com/en/aspirin.aspx
- F. E. Young et al, "The Preliminary Report of the Findings of the Aspirin Component of the Ongoing Physicians" Health Study, JAMA 1988
- http://www.heart.org/HEARTORG/Conditions/HeartAttack/LifeAfteraHeartAttack/Lifestyle-Changes-for-Heart-Attack-Prevention_UCM_303934_Article.jsp#.WIXzfsu7rcs